Interatrial shunting in heart failure: still alive, for whom, and with which concept
Friday, August 7, 2026 16:00 CEST
Moderators:
Horst Sievert, CardioVascular Center CVC Frankfurt, Germany
Gregg Stone, Mount Sinai Medical Center, New York City, USA
Gry Dahle, Oslo University Hospital, Oslo, Norway
Karl-Philipp Rommel, University Hospital Mainz, Center for Cardiology, Mainz, Germany
PROGRAM
Does left atrial decompression still make physiological sense? >> Roman Pfister, Uniklinik Köln, Cologne, Germany
What did the clinical trials really show? >> Gregg Stone, Mount Sinai Medical Center, New York City, USA
Who is the right patient? >> Nijad Bakhshaliyev, Ege Hospital, Baku, Azerbaijan
Device concept:
- V-Wave >> TBC
- Alleviant >> James Udelson, Tufts University School of Medicine, USA
- Occlutech AFR >> TBC
- InterShunt >> Sitaramesh Emani, The Christ Hospital, Cincinnati, USA
- APTURE >> Firas Zahr, Oregon Health & Science University, Portland, USA
Does device design matter? >> Martin W. Bergmann, Asklepios Clinic Altona, Hamburg, Germany
What should the next pivotal trial look like? >> John Spertus, University of Missouri, Kansas City, USA
Final rapid vote: would you implant today, and in whom? >> Horst Sievert, CardioVascular Center CVC Frankfurt, Germany
Sponsored by
